nodes	percent_of_prediction	percent_of_DWPC	metapath
Clofarabine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—pancreatic cancer	0.256	0.515	CiPCiCtD
Clofarabine—Nucleic Acid Synthesis Inhibitors—Fluorouracil—pancreatic cancer	0.241	0.485	CiPCiCtD
Clofarabine—RRM2—Gemcitabine—pancreatic cancer	0.0623	0.247	CbGbCtD
Clofarabine—RRM1—Gemcitabine—pancreatic cancer	0.0623	0.247	CbGbCtD
Clofarabine—Cytarabine—Gemcitabine—pancreatic cancer	0.0578	0.35	CrCrCtD
Clofarabine—Azacitidine—Gemcitabine—pancreatic cancer	0.0549	0.333	CrCrCtD
Clofarabine—POLA1—Gemcitabine—pancreatic cancer	0.0538	0.214	CbGbCtD
Clofarabine—Decitabine—Gemcitabine—pancreatic cancer	0.0523	0.317	CrCrCtD
Clofarabine—DCK—Gemcitabine—pancreatic cancer	0.0331	0.132	CbGbCtD
Clofarabine—ABCG2—Tamoxifen—pancreatic cancer	0.0082	0.0326	CbGbCtD
Clofarabine—ABCG2—Erlotinib—pancreatic cancer	0.00697	0.0277	CbGbCtD
Clofarabine—ABCG2—Irinotecan—pancreatic cancer	0.00629	0.025	CbGbCtD
Clofarabine—ABCG2—Fluorouracil—pancreatic cancer	0.00604	0.024	CbGbCtD
Clofarabine—ABCG2—Docetaxel—pancreatic cancer	0.00461	0.0183	CbGbCtD
Clofarabine—ABCG2—Sunitinib—pancreatic cancer	0.00459	0.0182	CbGbCtD
Clofarabine—ABCG2—Doxorubicin—pancreatic cancer	0.00344	0.0137	CbGbCtD
Clofarabine—Fludarabine—SLC29A1—pancreatic cancer	0.000555	0.346	CrCbGaD
Clofarabine—Ribavirin—SLC29A1—pancreatic cancer	0.000552	0.343	CrCbGaD
Clofarabine—RRM2—Gefitinib—Erlotinib—pancreatic cancer	0.000403	0.314	CbGdCrCtD
Clofarabine—Cytarabine—SLC29A1—pancreatic cancer	0.000358	0.223	CrCbGaD
Clofarabine—DCK—Topotecan—Irinotecan—pancreatic cancer	0.000339	0.265	CbGdCrCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000182	0.00694	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—TYMS—pancreatic cancer	0.000178	0.0068	CbGpPWpGaD
Clofarabine—RRM1—Azacitidine—Gemcitabine—pancreatic cancer	0.000173	0.135	CbGdCrCtD
Clofarabine—RRM1—Nucleotide metabolism—TYMS—pancreatic cancer	0.000169	0.00645	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000162	0.00619	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—SYCP1—pancreatic cancer	0.000159	0.00608	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000155	0.00591	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000147	0.00562	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—PLAU—pancreatic cancer	0.000147	0.00561	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—TYMS—pancreatic cancer	0.000147	0.0056	CbGpPWpGaD
Clofarabine—Adenosine monophosphate—SRC—pancreatic cancer	0.000143	0.0888	CrCbGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—NDRG1—pancreatic cancer	0.00014	0.00535	CbGpPWpGaD
Clofarabine—RRM2—Nucleotide metabolism—TYMS—pancreatic cancer	0.000139	0.00531	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000132	0.00504	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000131	0.00498	CbGpPWpGaD
Clofarabine—DCK—Nucleotide metabolism—TYMS—pancreatic cancer	0.00013	0.00497	CbGpPWpGaD
Clofarabine—POLA1—E2F mediated regulation of DNA replication—RB1—pancreatic cancer	0.000129	0.0049	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000128	0.00487	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—PLAU—pancreatic cancer	0.000121	0.00462	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—RB1—pancreatic cancer	0.000121	0.00461	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000119	0.00455	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000118	0.00449	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000114	0.00435	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000112	0.00428	CbGpPWpGaD
Clofarabine—RRM1—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000112	0.00426	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—SYCP1—pancreatic cancer	0.000109	0.00416	CbGpPWpGaD
Clofarabine—RRM2—Azacitidine—Gemcitabine—pancreatic cancer	0.000109	0.0848	CbGdCrCtD
Clofarabine—RRM2—G1/S Transition—TYMS—pancreatic cancer	0.000107	0.00407	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000106	0.00405	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000105	0.00401	CbGpPWpGaD
Clofarabine—DCK—Clomifene—Tamoxifen—pancreatic cancer	0.000104	0.0815	CbGdCrCtD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000104	0.00395	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—GADD45A—pancreatic cancer	0.000103	0.00391	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—TYMS—pancreatic cancer	0.000101	0.00383	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—RB1—pancreatic cancer	9.96e-05	0.0038	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	9.61e-05	0.00366	CbGpPWpGaD
Clofarabine—RRM2—Fluoropyrimidine Activity—TP53—pancreatic cancer	9.2e-05	0.00351	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—TYMS—pancreatic cancer	8.99e-05	0.00343	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—CDKN2A—pancreatic cancer	8.76e-05	0.00334	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	8.74e-05	0.00333	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	8.69e-05	0.00331	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	8.66e-05	0.0033	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	8.42e-05	0.00321	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	8.31e-05	0.00317	CbGpPWpGaD
Clofarabine—POLA1—Telomere Maintenance—TERT—pancreatic cancer	8.31e-05	0.00317	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—PLAU—pancreatic cancer	8.29e-05	0.00316	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	8.27e-05	0.00315	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RBBP8—pancreatic cancer	8.16e-05	0.00311	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	8.09e-05	0.00308	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—KDR—pancreatic cancer	8.07e-05	0.00308	CbGpPWpGaD
Clofarabine—DCK—Doxorubicin—Epirubicin—pancreatic cancer	7.97e-05	0.0622	CbGdCrCtD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	7.81e-05	0.00298	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	7.45e-05	0.00284	CbGpPWpGaD
Clofarabine—DCK—Epirubicin—Doxorubicin—pancreatic cancer	7.38e-05	0.0576	CbGdCrCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	7.36e-05	0.00281	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—TYMS—pancreatic cancer	7.29e-05	0.00278	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—RB1—pancreatic cancer	7.23e-05	0.00276	CbGpPWpGaD
Clofarabine—RRM1—E2F transcription factor network—MYC—pancreatic cancer	7.21e-05	0.00275	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	7.1e-05	0.00271	CbGpPWpGaD
Clofarabine—POLA1—Chromosome Maintenance—TERT—pancreatic cancer	6.92e-05	0.00264	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—RB1—pancreatic cancer	6.82e-05	0.0026	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—PPP2R5B—pancreatic cancer	6.49e-05	0.00247	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	6.43e-05	0.00245	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	6.43e-05	0.00245	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—PPP2R5B—pancreatic cancer	6.34e-05	0.00242	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	6.32e-05	0.00241	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	6.32e-05	0.00241	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	6.27e-05	0.00239	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	6.26e-05	0.00239	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—TYMS—pancreatic cancer	6.15e-05	0.00234	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—RB1—pancreatic cancer	6.09e-05	0.00232	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—SMAD4—pancreatic cancer	6.07e-05	0.00231	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	6.01e-05	0.00229	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	6e-05	0.00229	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—CDKN2A—pancreatic cancer	5.99e-05	0.00228	CbGpPWpGaD
Clofarabine—RRM2—E2F transcription factor network—MYC—pancreatic cancer	5.94e-05	0.00226	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	5.92e-05	0.00226	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—FOXM1—pancreatic cancer	5.66e-05	0.00216	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—RBBP8—pancreatic cancer	5.58e-05	0.00213	CbGpPWpGaD
Clofarabine—POLA1—Synthesis of DNA—RB1—pancreatic cancer	5.47e-05	0.00209	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	5.47e-05	0.00208	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	5.41e-05	0.00206	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	5.36e-05	0.00204	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—TERT—pancreatic cancer	5.19e-05	0.00198	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	5.16e-05	0.00197	CbGpPWpGaD
Clofarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	5.14e-05	0.00196	CbGpPWpGaD
Clofarabine—POLA1—DNA Replication—RB1—pancreatic cancer	5.13e-05	0.00196	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—HIF1A—pancreatic cancer	4.96e-05	0.00189	CbGpPWpGaD
Clofarabine—POLA1—G1/S Transition—RB1—pancreatic cancer	4.95e-05	0.00189	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	4.9e-05	0.00187	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	4.85e-05	0.00185	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	4.82e-05	0.00184	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	4.74e-05	0.00181	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	4.66e-05	0.00178	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	4.61e-05	0.00176	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	4.53e-05	0.00173	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PRSS1—pancreatic cancer	4.49e-05	0.00171	CbGpPWpGaD
Clofarabine—POLA1—S Phase—RB1—pancreatic cancer	4.49e-05	0.00171	CbGpPWpGaD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	4.46e-05	0.0017	CbGpPWpGaD
Clofarabine—ABCG2—HIF-2-alpha transcription factor network—VEGFA—pancreatic cancer	4.45e-05	0.00169	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	4.4e-05	0.00168	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—PPP2R5B—pancreatic cancer	4.34e-05	0.00165	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	4.33e-05	0.00165	CbGpPWpGaD
Clofarabine—RRM2—G1/S Transition—MYC—pancreatic cancer	4.31e-05	0.00164	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	4.28e-05	0.00163	CbGpPWpGaD
Clofarabine—RRM2—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	4.24e-05	0.00161	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—RB1—pancreatic cancer	4.17e-05	0.00159	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	4.16e-05	0.00159	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	4.12e-05	0.00157	CbGpPWpGaD
Clofarabine—POLA1—E2F transcription factor network—MYC—pancreatic cancer	4.06e-05	0.00155	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	4.02e-05	0.00153	CbGpPWpGaD
Clofarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	3.96e-05	0.00151	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—ARG2—pancreatic cancer	3.89e-05	0.00148	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—FOXM1—pancreatic cancer	3.87e-05	0.00147	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	3.73e-05	0.00142	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PRSS1—pancreatic cancer	3.7e-05	0.00141	CbGpPWpGaD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	3.66e-05	0.0014	CbGpPWpGaD
Clofarabine—RRM2—Mitotic G1-G1/S phases—MYC—pancreatic cancer	3.63e-05	0.00138	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	3.63e-05	0.00138	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	3.53e-05	0.00135	CbGpPWpGaD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	3.53e-05	0.00135	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PRSS1—pancreatic cancer	3.46e-05	0.00132	CbGpPWpGaD
Clofarabine—ABCG2—Fluoropyrimidine Activity—TP53—pancreatic cancer	3.44e-05	0.00131	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—TYMP—pancreatic cancer	3.4e-05	0.0013	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	3.38e-05	0.00129	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	3.34e-05	0.00127	CbGpPWpGaD
Clofarabine—POLA1—S Phase—CCND1—pancreatic cancer	3.33e-05	0.00127	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	3.33e-05	0.00127	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—TYMS—pancreatic cancer	3.3e-05	0.00126	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	3.27e-05	0.00125	CbGpPWpGaD
Clofarabine—Erythema—Docetaxel—pancreatic cancer	3.26e-05	0.000574	CcSEcCtD
Clofarabine—Malnutrition—Docetaxel—pancreatic cancer	3.26e-05	0.000574	CcSEcCtD
Clofarabine—Decreased appetite—Gemcitabine—pancreatic cancer	3.26e-05	0.000574	CcSEcCtD
Clofarabine—Nausea—Tamoxifen—pancreatic cancer	3.24e-05	0.00057	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	3.24e-05	0.00057	CcSEcCtD
Clofarabine—Fatigue—Gemcitabine—pancreatic cancer	3.23e-05	0.000569	CcSEcCtD
Clofarabine—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	3.22e-05	0.000567	CcSEcCtD
Clofarabine—Pain—Gemcitabine—pancreatic cancer	3.21e-05	0.000564	CcSEcCtD
Clofarabine—Nausea—Erlotinib—pancreatic cancer	3.21e-05	0.000564	CcSEcCtD
Clofarabine—RRM2—Metabolism—ARG2—pancreatic cancer	3.21e-05	0.00122	CbGpPWpGaD
Clofarabine—Decreased appetite—Fluorouracil—pancreatic cancer	3.2e-05	0.000564	CcSEcCtD
Clofarabine—Diarrhoea—Sunitinib—pancreatic cancer	3.2e-05	0.000563	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	3.18e-05	0.00056	CcSEcCtD
Clofarabine—Feeling abnormal—Irinotecan—pancreatic cancer	3.17e-05	0.000558	CcSEcCtD
Clofarabine—Blood creatinine increased—Doxorubicin—pancreatic cancer	3.16e-05	0.000557	CcSEcCtD
Clofarabine—Influenza—Epirubicin—pancreatic cancer	3.16e-05	0.000555	CcSEcCtD
Clofarabine—Back pain—Docetaxel—pancreatic cancer	3.15e-05	0.000555	CcSEcCtD
Clofarabine—Pain—Fluorouracil—pancreatic cancer	3.15e-05	0.000555	CcSEcCtD
Clofarabine—Gastrointestinal pain—Irinotecan—pancreatic cancer	3.15e-05	0.000554	CcSEcCtD
Clofarabine—Dehydration—Doxorubicin—pancreatic cancer	3.14e-05	0.000553	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	3.11e-05	0.00119	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—BRCA2—pancreatic cancer	3.1e-05	0.00118	CbGpPWpGaD
Clofarabine—Dry skin—Doxorubicin—pancreatic cancer	3.1e-05	0.000545	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	3.1e-05	0.00118	CbGpPWpGaD
Clofarabine—Pancreatitis—Epirubicin—pancreatic cancer	3.09e-05	0.000545	CcSEcCtD
Clofarabine—Dizziness—Sunitinib—pancreatic cancer	3.09e-05	0.000544	CcSEcCtD
Clofarabine—Feeling abnormal—Gemcitabine—pancreatic cancer	3.09e-05	0.000544	CcSEcCtD
Clofarabine—Abdominal pain upper—Doxorubicin—pancreatic cancer	3.09e-05	0.000543	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	3.09e-05	0.00118	CbGpPWpGaD
Clofarabine—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	3.05e-05	0.00116	CbGpPWpGaD
Clofarabine—Body temperature increased—Irinotecan—pancreatic cancer	3.04e-05	0.000536	CcSEcCtD
Clofarabine—Abdominal pain—Irinotecan—pancreatic cancer	3.04e-05	0.000536	CcSEcCtD
Clofarabine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	3.04e-05	0.000536	CcSEcCtD
Clofarabine—Aspartate aminotransferase increased—Doxorubicin—pancreatic cancer	3.04e-05	0.000536	CcSEcCtD
Clofarabine—Feeling abnormal—Fluorouracil—pancreatic cancer	3.04e-05	0.000535	CcSEcCtD
Clofarabine—Anaemia—Docetaxel—pancreatic cancer	3.01e-05	0.00053	CcSEcCtD
Clofarabine—Pancytopenia—Epirubicin—pancreatic cancer	3e-05	0.000528	CcSEcCtD
Clofarabine—DCK—Metabolism—ARG2—pancreatic cancer	3e-05	0.00114	CbGpPWpGaD
Clofarabine—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	2.98e-05	0.000525	CcSEcCtD
Clofarabine—Vomiting—Sunitinib—pancreatic cancer	2.97e-05	0.000523	CcSEcCtD
Clofarabine—Body temperature increased—Gemcitabine—pancreatic cancer	2.96e-05	0.000522	CcSEcCtD
Clofarabine—Neutropenia—Epirubicin—pancreatic cancer	2.95e-05	0.000519	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TYMS—pancreatic cancer	2.95e-05	0.00112	CbGpPWpGaD
Clofarabine—Rash—Sunitinib—pancreatic cancer	2.95e-05	0.000519	CcSEcCtD
Clofarabine—POLA1—G1/S Transition—MYC—pancreatic cancer	2.95e-05	0.00112	CbGpPWpGaD
Clofarabine—Dermatitis—Sunitinib—pancreatic cancer	2.94e-05	0.000518	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	2.93e-05	0.000516	CcSEcCtD
Clofarabine—Headache—Sunitinib—pancreatic cancer	2.93e-05	0.000515	CcSEcCtD
Clofarabine—Influenza—Doxorubicin—pancreatic cancer	2.92e-05	0.000514	CcSEcCtD
Clofarabine—Leukopenia—Docetaxel—pancreatic cancer	2.92e-05	0.000514	CcSEcCtD
Clofarabine—Body temperature increased—Fluorouracil—pancreatic cancer	2.91e-05	0.000513	CcSEcCtD
Clofarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	2.9e-05	0.0011	CbGpPWpGaD
Clofarabine—Pancreatitis—Doxorubicin—pancreatic cancer	2.86e-05	0.000504	CcSEcCtD
Clofarabine—Weight decreased—Epirubicin—pancreatic cancer	2.86e-05	0.000503	CcSEcCtD
Clofarabine—Cough—Docetaxel—pancreatic cancer	2.84e-05	0.000501	CcSEcCtD
Clofarabine—Hypersensitivity—Irinotecan—pancreatic cancer	2.84e-05	0.000499	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.83e-05	0.00108	CbGpPWpGaD
Clofarabine—Pneumonia—Epirubicin—pancreatic cancer	2.83e-05	0.000498	CcSEcCtD
Clofarabine—Hypertension—Docetaxel—pancreatic cancer	2.81e-05	0.000495	CcSEcCtD
Clofarabine—Infestation—Epirubicin—pancreatic cancer	2.81e-05	0.000495	CcSEcCtD
Clofarabine—Infestation NOS—Epirubicin—pancreatic cancer	2.81e-05	0.000495	CcSEcCtD
Clofarabine—RRM2—Metabolism—TYMP—pancreatic cancer	2.8e-05	0.00107	CbGpPWpGaD
Clofarabine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	2.79e-05	0.000491	CcSEcCtD
Clofarabine—Arthralgia—Docetaxel—pancreatic cancer	2.78e-05	0.000489	CcSEcCtD
Clofarabine—Myalgia—Docetaxel—pancreatic cancer	2.78e-05	0.000489	CcSEcCtD
Clofarabine—Nausea—Sunitinib—pancreatic cancer	2.78e-05	0.000489	CcSEcCtD
Clofarabine—Pancytopenia—Doxorubicin—pancreatic cancer	2.77e-05	0.000488	CcSEcCtD
Clofarabine—Renal failure—Epirubicin—pancreatic cancer	2.77e-05	0.000487	CcSEcCtD
Clofarabine—Asthenia—Irinotecan—pancreatic cancer	2.76e-05	0.000486	CcSEcCtD
Clofarabine—Neuropathy peripheral—Epirubicin—pancreatic cancer	2.76e-05	0.000486	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	2.76e-05	0.000485	CcSEcCtD
Clofarabine—RRM1—Metabolism—GLP1R—pancreatic cancer	2.74e-05	0.00105	CbGpPWpGaD
Clofarabine—Jaundice—Epirubicin—pancreatic cancer	2.74e-05	0.000483	CcSEcCtD
Clofarabine—Stomatitis—Epirubicin—pancreatic cancer	2.74e-05	0.000483	CcSEcCtD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.74e-05	0.00105	CbGpPWpGaD
Clofarabine—Neutropenia—Doxorubicin—pancreatic cancer	2.73e-05	0.000481	CcSEcCtD
Clofarabine—Hypersensitivity—Fluorouracil—pancreatic cancer	2.72e-05	0.000478	CcSEcCtD
Clofarabine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	2.71e-05	0.000478	CcSEcCtD
Clofarabine—RRM1—Metabolism—DPYD—pancreatic cancer	2.7e-05	0.00103	CbGpPWpGaD
Clofarabine—Asthenia—Gemcitabine—pancreatic cancer	2.69e-05	0.000474	CcSEcCtD
Clofarabine—Haematuria—Epirubicin—pancreatic cancer	2.68e-05	0.000472	CcSEcCtD
Clofarabine—POLA1—S Phase—MYC—pancreatic cancer	2.67e-05	0.00102	CbGpPWpGaD
Clofarabine—Hepatobiliary disease—Epirubicin—pancreatic cancer	2.66e-05	0.000468	CcSEcCtD
Clofarabine—Oedema—Docetaxel—pancreatic cancer	2.66e-05	0.000468	CcSEcCtD
Clofarabine—Epistaxis—Epirubicin—pancreatic cancer	2.65e-05	0.000467	CcSEcCtD
Clofarabine—Pruritus—Gemcitabine—pancreatic cancer	2.65e-05	0.000467	CcSEcCtD
Clofarabine—Infection—Docetaxel—pancreatic cancer	2.64e-05	0.000465	CcSEcCtD
Clofarabine—Weight decreased—Doxorubicin—pancreatic cancer	2.64e-05	0.000465	CcSEcCtD
Clofarabine—Sinusitis—Epirubicin—pancreatic cancer	2.64e-05	0.000465	CcSEcCtD
Clofarabine—Diarrhoea—Irinotecan—pancreatic cancer	2.63e-05	0.000464	CcSEcCtD
Clofarabine—Pneumonia—Doxorubicin—pancreatic cancer	2.62e-05	0.000461	CcSEcCtD
Clofarabine—DCK—Metabolism—TYMP—pancreatic cancer	2.62e-05	0.000998	CbGpPWpGaD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	2.62e-05	0.000997	CbGpPWpGaD
Clofarabine—Nervous system disorder—Docetaxel—pancreatic cancer	2.61e-05	0.000459	CcSEcCtD
Clofarabine—Pruritus—Fluorouracil—pancreatic cancer	2.61e-05	0.000459	CcSEcCtD
Clofarabine—Thrombocytopenia—Docetaxel—pancreatic cancer	2.61e-05	0.000459	CcSEcCtD
Clofarabine—Infestation—Doxorubicin—pancreatic cancer	2.6e-05	0.000458	CcSEcCtD
Clofarabine—Infestation NOS—Doxorubicin—pancreatic cancer	2.6e-05	0.000458	CcSEcCtD
Clofarabine—Tachycardia—Docetaxel—pancreatic cancer	2.6e-05	0.000457	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	2.6e-05	0.000989	CbGpPWpGaD
Clofarabine—Skin disorder—Docetaxel—pancreatic cancer	2.58e-05	0.000455	CcSEcCtD
Clofarabine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	2.58e-05	0.000454	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TERT—pancreatic cancer	2.57e-05	0.000979	CbGpPWpGaD
Clofarabine—Diarrhoea—Gemcitabine—pancreatic cancer	2.57e-05	0.000452	CcSEcCtD
Clofarabine—RRM1—Metabolism—SLC2A2—pancreatic cancer	2.56e-05	0.000976	CbGpPWpGaD
Clofarabine—Renal failure—Doxorubicin—pancreatic cancer	2.56e-05	0.00045	CcSEcCtD
Clofarabine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	2.55e-05	0.000449	CcSEcCtD
Clofarabine—Dizziness—Irinotecan—pancreatic cancer	2.55e-05	0.000448	CcSEcCtD
Clofarabine—Haemoglobin—Epirubicin—pancreatic cancer	2.54e-05	0.000447	CcSEcCtD
Clofarabine—Jaundice—Doxorubicin—pancreatic cancer	2.54e-05	0.000447	CcSEcCtD
Clofarabine—Stomatitis—Doxorubicin—pancreatic cancer	2.54e-05	0.000447	CcSEcCtD
Clofarabine—Anorexia—Docetaxel—pancreatic cancer	2.54e-05	0.000446	CcSEcCtD
Clofarabine—Haemorrhage—Epirubicin—pancreatic cancer	2.53e-05	0.000445	CcSEcCtD
Clofarabine—Diarrhoea—Fluorouracil—pancreatic cancer	2.52e-05	0.000444	CcSEcCtD
Clofarabine—Urinary tract disorder—Epirubicin—pancreatic cancer	2.49e-05	0.000439	CcSEcCtD
Clofarabine—Oedema peripheral—Epirubicin—pancreatic cancer	2.49e-05	0.000438	CcSEcCtD
Clofarabine—Hypotension—Docetaxel—pancreatic cancer	2.49e-05	0.000438	CcSEcCtD
Clofarabine—POLA1—Mitotic G1-G1/S phases—MYC—pancreatic cancer	2.48e-05	0.000946	CbGpPWpGaD
Clofarabine—Haematuria—Doxorubicin—pancreatic cancer	2.48e-05	0.000437	CcSEcCtD
Clofarabine—Connective tissue disorder—Epirubicin—pancreatic cancer	2.48e-05	0.000437	CcSEcCtD
Clofarabine—Urethral disorder—Epirubicin—pancreatic cancer	2.48e-05	0.000436	CcSEcCtD
Clofarabine—Hepatobiliary disease—Doxorubicin—pancreatic cancer	2.46e-05	0.000433	CcSEcCtD
Clofarabine—Epistaxis—Doxorubicin—pancreatic cancer	2.46e-05	0.000432	CcSEcCtD
Clofarabine—Vomiting—Irinotecan—pancreatic cancer	2.45e-05	0.000431	CcSEcCtD
Clofarabine—Sinusitis—Doxorubicin—pancreatic cancer	2.44e-05	0.00043	CcSEcCtD
Clofarabine—Dizziness—Fluorouracil—pancreatic cancer	2.44e-05	0.000429	CcSEcCtD
Clofarabine—Rash—Irinotecan—pancreatic cancer	2.43e-05	0.000427	CcSEcCtD
Clofarabine—Dermatitis—Irinotecan—pancreatic cancer	2.42e-05	0.000427	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	2.42e-05	0.000427	CcSEcCtD
Clofarabine—Headache—Irinotecan—pancreatic cancer	2.41e-05	0.000424	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	2.41e-05	0.000918	CbGpPWpGaD
Clofarabine—Paraesthesia—Docetaxel—pancreatic cancer	2.39e-05	0.000421	CcSEcCtD
Clofarabine—Erythema multiforme—Epirubicin—pancreatic cancer	2.39e-05	0.00042	CcSEcCtD
Clofarabine—Vomiting—Gemcitabine—pancreatic cancer	2.38e-05	0.00042	CcSEcCtD
Clofarabine—Dyspnoea—Docetaxel—pancreatic cancer	2.37e-05	0.000418	CcSEcCtD
Clofarabine—Somnolence—Docetaxel—pancreatic cancer	2.37e-05	0.000416	CcSEcCtD
Clofarabine—Rash—Gemcitabine—pancreatic cancer	2.36e-05	0.000416	CcSEcCtD
Clofarabine—Dermatitis—Gemcitabine—pancreatic cancer	2.36e-05	0.000416	CcSEcCtD
Clofarabine—Haemoglobin—Doxorubicin—pancreatic cancer	2.35e-05	0.000413	CcSEcCtD
Clofarabine—Headache—Gemcitabine—pancreatic cancer	2.35e-05	0.000413	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	2.34e-05	0.000894	CbGpPWpGaD
Clofarabine—Flushing—Epirubicin—pancreatic cancer	2.34e-05	0.000413	CcSEcCtD
Clofarabine—Cardiac disorder—Epirubicin—pancreatic cancer	2.34e-05	0.000413	CcSEcCtD
Clofarabine—Vomiting—Fluorouracil—pancreatic cancer	2.34e-05	0.000413	CcSEcCtD
Clofarabine—Haemorrhage—Doxorubicin—pancreatic cancer	2.34e-05	0.000411	CcSEcCtD
Clofarabine—Rash—Fluorouracil—pancreatic cancer	2.32e-05	0.000409	CcSEcCtD
Clofarabine—Dermatitis—Fluorouracil—pancreatic cancer	2.32e-05	0.000409	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	2.32e-05	0.000885	CbGpPWpGaD
Clofarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	2.32e-05	0.000883	CbGpPWpGaD
Clofarabine—Decreased appetite—Docetaxel—pancreatic cancer	2.31e-05	0.000407	CcSEcCtD
Clofarabine—Headache—Fluorouracil—pancreatic cancer	2.31e-05	0.000407	CcSEcCtD
Clofarabine—Urinary tract disorder—Doxorubicin—pancreatic cancer	2.31e-05	0.000406	CcSEcCtD
Clofarabine—Oedema peripheral—Doxorubicin—pancreatic cancer	2.3e-05	0.000405	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	2.3e-05	0.000404	CcSEcCtD
Clofarabine—Connective tissue disorder—Doxorubicin—pancreatic cancer	2.3e-05	0.000404	CcSEcCtD
Clofarabine—Fatigue—Docetaxel—pancreatic cancer	2.29e-05	0.000404	CcSEcCtD
Clofarabine—Angiopathy—Epirubicin—pancreatic cancer	2.29e-05	0.000403	CcSEcCtD
Clofarabine—Urethral disorder—Doxorubicin—pancreatic cancer	2.29e-05	0.000403	CcSEcCtD
Clofarabine—Nausea—Irinotecan—pancreatic cancer	2.29e-05	0.000402	CcSEcCtD
Clofarabine—Immune system disorder—Epirubicin—pancreatic cancer	2.28e-05	0.000402	CcSEcCtD
Clofarabine—Mediastinal disorder—Epirubicin—pancreatic cancer	2.28e-05	0.000401	CcSEcCtD
Clofarabine—Pain—Docetaxel—pancreatic cancer	2.28e-05	0.0004	CcSEcCtD
Clofarabine—Chills—Epirubicin—pancreatic cancer	2.27e-05	0.000399	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	2.26e-05	0.000863	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—GLP1R—pancreatic cancer	2.26e-05	0.000861	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—TYMS—pancreatic cancer	2.25e-05	0.000859	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—RB1—pancreatic cancer	2.23e-05	0.000852	CbGpPWpGaD
Clofarabine—Alopecia—Epirubicin—pancreatic cancer	2.23e-05	0.000393	CcSEcCtD
Clofarabine—Nausea—Gemcitabine—pancreatic cancer	2.23e-05	0.000392	CcSEcCtD
Clofarabine—RRM2—Metabolism—DPYD—pancreatic cancer	2.22e-05	0.000847	CbGpPWpGaD
Clofarabine—Mental disorder—Epirubicin—pancreatic cancer	2.21e-05	0.00039	CcSEcCtD
Clofarabine—Erythema multiforme—Doxorubicin—pancreatic cancer	2.21e-05	0.000389	CcSEcCtD
Clofarabine—Malnutrition—Epirubicin—pancreatic cancer	2.2e-05	0.000387	CcSEcCtD
Clofarabine—Erythema—Epirubicin—pancreatic cancer	2.2e-05	0.000387	CcSEcCtD
Clofarabine—Feeling abnormal—Docetaxel—pancreatic cancer	2.19e-05	0.000386	CcSEcCtD
Clofarabine—Nausea—Fluorouracil—pancreatic cancer	2.19e-05	0.000385	CcSEcCtD
Clofarabine—Gastrointestinal pain—Docetaxel—pancreatic cancer	2.18e-05	0.000383	CcSEcCtD
Clofarabine—Cardiac disorder—Doxorubicin—pancreatic cancer	2.17e-05	0.000382	CcSEcCtD
Clofarabine—Flushing—Doxorubicin—pancreatic cancer	2.17e-05	0.000382	CcSEcCtD
Clofarabine—Back pain—Epirubicin—pancreatic cancer	2.13e-05	0.000374	CcSEcCtD
Clofarabine—Angiopathy—Doxorubicin—pancreatic cancer	2.12e-05	0.000373	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—BRCA2—pancreatic cancer	2.12e-05	0.000808	CbGpPWpGaD
Clofarabine—Immune system disorder—Doxorubicin—pancreatic cancer	2.11e-05	0.000372	CcSEcCtD
Clofarabine—DCK—Metabolism—GLP1R—pancreatic cancer	2.11e-05	0.000805	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—SLC2A2—pancreatic cancer	2.11e-05	0.000804	CbGpPWpGaD
Clofarabine—Mediastinal disorder—Doxorubicin—pancreatic cancer	2.11e-05	0.000371	CcSEcCtD
Clofarabine—Abdominal pain—Docetaxel—pancreatic cancer	2.1e-05	0.00037	CcSEcCtD
Clofarabine—Body temperature increased—Docetaxel—pancreatic cancer	2.1e-05	0.00037	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.1e-05	0.0008	CbGpPWpGaD
Clofarabine—Chills—Doxorubicin—pancreatic cancer	2.1e-05	0.000369	CcSEcCtD
Clofarabine—DCK—Metabolism—DPYD—pancreatic cancer	2.08e-05	0.000792	CbGpPWpGaD
Clofarabine—Alopecia—Doxorubicin—pancreatic cancer	2.07e-05	0.000364	CcSEcCtD
Clofarabine—Mental disorder—Doxorubicin—pancreatic cancer	2.05e-05	0.00036	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.04e-05	0.000779	CbGpPWpGaD
Clofarabine—POLA1—Mitotic M-M/G1 phases—RB1—pancreatic cancer	2.04e-05	0.000779	CbGpPWpGaD
Clofarabine—Erythema—Doxorubicin—pancreatic cancer	2.03e-05	0.000358	CcSEcCtD
Clofarabine—Malnutrition—Doxorubicin—pancreatic cancer	2.03e-05	0.000358	CcSEcCtD
Clofarabine—Anaemia—Epirubicin—pancreatic cancer	2.03e-05	0.000358	CcSEcCtD
Clofarabine—Agitation—Epirubicin—pancreatic cancer	2.02e-05	0.000356	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—TYMS—pancreatic cancer	2.02e-05	0.000768	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle—RB1—pancreatic cancer	2e-05	0.000762	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—CD44—pancreatic cancer	1.98e-05	0.000756	CbGpPWpGaD
Clofarabine—DCK—Metabolism—SLC2A2—pancreatic cancer	1.97e-05	0.000751	CbGpPWpGaD
Clofarabine—Leukopenia—Epirubicin—pancreatic cancer	1.97e-05	0.000346	CcSEcCtD
Clofarabine—Back pain—Doxorubicin—pancreatic cancer	1.97e-05	0.000346	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	1.96e-05	0.000749	CbGpPWpGaD
Clofarabine—Hypersensitivity—Docetaxel—pancreatic cancer	1.96e-05	0.000345	CcSEcCtD
Clofarabine—Cough—Epirubicin—pancreatic cancer	1.92e-05	0.000338	CcSEcCtD
Clofarabine—Asthenia—Docetaxel—pancreatic cancer	1.91e-05	0.000336	CcSEcCtD
Clofarabine—RRM1—Metabolism—GCG—pancreatic cancer	1.9e-05	0.000725	CbGpPWpGaD
Clofarabine—Hypertension—Epirubicin—pancreatic cancer	1.9e-05	0.000334	CcSEcCtD
Clofarabine—Pruritus—Docetaxel—pancreatic cancer	1.88e-05	0.000331	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	1.88e-05	0.000717	CbGpPWpGaD
Clofarabine—Anaemia—Doxorubicin—pancreatic cancer	1.88e-05	0.000331	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	1.88e-05	0.000715	CbGpPWpGaD
Clofarabine—Myalgia—Epirubicin—pancreatic cancer	1.87e-05	0.00033	CcSEcCtD
Clofarabine—Arthralgia—Epirubicin—pancreatic cancer	1.87e-05	0.00033	CcSEcCtD
Clofarabine—Agitation—Doxorubicin—pancreatic cancer	1.87e-05	0.000329	CcSEcCtD
Clofarabine—Anxiety—Epirubicin—pancreatic cancer	1.87e-05	0.000328	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	1.86e-05	0.000327	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	1.84e-05	0.000701	CbGpPWpGaD
Clofarabine—Leukopenia—Doxorubicin—pancreatic cancer	1.82e-05	0.000321	CcSEcCtD
Clofarabine—Diarrhoea—Docetaxel—pancreatic cancer	1.82e-05	0.00032	CcSEcCtD
Clofarabine—Oedema—Epirubicin—pancreatic cancer	1.79e-05	0.000316	CcSEcCtD
Clofarabine—RRM1—Metabolism—STK11—pancreatic cancer	1.79e-05	0.000681	CbGpPWpGaD
Clofarabine—Infection—Epirubicin—pancreatic cancer	1.78e-05	0.000314	CcSEcCtD
Clofarabine—Cough—Doxorubicin—pancreatic cancer	1.78e-05	0.000313	CcSEcCtD
Clofarabine—Nervous system disorder—Epirubicin—pancreatic cancer	1.76e-05	0.00031	CcSEcCtD
Clofarabine—Dizziness—Docetaxel—pancreatic cancer	1.76e-05	0.00031	CcSEcCtD
Clofarabine—Thrombocytopenia—Epirubicin—pancreatic cancer	1.76e-05	0.000309	CcSEcCtD
Clofarabine—Hypertension—Doxorubicin—pancreatic cancer	1.76e-05	0.000309	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CDKN2A—pancreatic cancer	1.76e-05	0.00067	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TERT—pancreatic cancer	1.76e-05	0.000669	CbGpPWpGaD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	1.75e-05	0.000668	CbGpPWpGaD
Clofarabine—Tachycardia—Epirubicin—pancreatic cancer	1.75e-05	0.000308	CcSEcCtD
Clofarabine—Skin disorder—Epirubicin—pancreatic cancer	1.74e-05	0.000307	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	1.74e-05	0.000663	CbGpPWpGaD
Clofarabine—Hyperhidrosis—Epirubicin—pancreatic cancer	1.73e-05	0.000305	CcSEcCtD
Clofarabine—Arthralgia—Doxorubicin—pancreatic cancer	1.73e-05	0.000305	CcSEcCtD
Clofarabine—Myalgia—Doxorubicin—pancreatic cancer	1.73e-05	0.000305	CcSEcCtD
Clofarabine—Anxiety—Doxorubicin—pancreatic cancer	1.73e-05	0.000304	CcSEcCtD
Clofarabine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	1.72e-05	0.000303	CcSEcCtD
Clofarabine—Anorexia—Epirubicin—pancreatic cancer	1.71e-05	0.000301	CcSEcCtD
Clofarabine—Vomiting—Docetaxel—pancreatic cancer	1.69e-05	0.000298	CcSEcCtD
Clofarabine—ABCG2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.68e-05	0.000642	CbGpPWpGaD
Clofarabine—Rash—Docetaxel—pancreatic cancer	1.68e-05	0.000295	CcSEcCtD
Clofarabine—Hypotension—Epirubicin—pancreatic cancer	1.68e-05	0.000295	CcSEcCtD
Clofarabine—Dermatitis—Docetaxel—pancreatic cancer	1.68e-05	0.000295	CcSEcCtD
Clofarabine—ABCG2—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.67e-05	0.000636	CbGpPWpGaD
Clofarabine—Headache—Docetaxel—pancreatic cancer	1.67e-05	0.000293	CcSEcCtD
Clofarabine—Oedema—Doxorubicin—pancreatic cancer	1.66e-05	0.000292	CcSEcCtD
Clofarabine—RRM2—Cell Cycle, Mitotic—CCND1—pancreatic cancer	1.66e-05	0.000633	CbGpPWpGaD
Clofarabine—Infection—Doxorubicin—pancreatic cancer	1.65e-05	0.00029	CcSEcCtD
Clofarabine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	1.63e-05	0.000288	CcSEcCtD
Clofarabine—RRM2—Metabolism—CD44—pancreatic cancer	1.63e-05	0.000623	CbGpPWpGaD
Clofarabine—Nervous system disorder—Doxorubicin—pancreatic cancer	1.63e-05	0.000287	CcSEcCtD
Clofarabine—Thrombocytopenia—Doxorubicin—pancreatic cancer	1.63e-05	0.000286	CcSEcCtD
Clofarabine—Tachycardia—Doxorubicin—pancreatic cancer	1.62e-05	0.000285	CcSEcCtD
Clofarabine—Skin disorder—Doxorubicin—pancreatic cancer	1.61e-05	0.000284	CcSEcCtD
Clofarabine—Paraesthesia—Epirubicin—pancreatic cancer	1.61e-05	0.000284	CcSEcCtD
Clofarabine—Hyperhidrosis—Doxorubicin—pancreatic cancer	1.61e-05	0.000283	CcSEcCtD
Clofarabine—Dyspnoea—Epirubicin—pancreatic cancer	1.6e-05	0.000282	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	1.6e-05	0.000609	CbGpPWpGaD
Clofarabine—Somnolence—Epirubicin—pancreatic cancer	1.6e-05	0.000281	CcSEcCtD
Clofarabine—Anorexia—Doxorubicin—pancreatic cancer	1.58e-05	0.000279	CcSEcCtD
Clofarabine—Nausea—Docetaxel—pancreatic cancer	1.58e-05	0.000278	CcSEcCtD
Clofarabine—RRM2—Metabolism—GCG—pancreatic cancer	1.57e-05	0.000597	CbGpPWpGaD
Clofarabine—Decreased appetite—Epirubicin—pancreatic cancer	1.56e-05	0.000275	CcSEcCtD
Clofarabine—Hypotension—Doxorubicin—pancreatic cancer	1.55e-05	0.000273	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	1.55e-05	0.000273	CcSEcCtD
Clofarabine—Fatigue—Epirubicin—pancreatic cancer	1.55e-05	0.000272	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	1.54e-05	0.000589	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—TYMS—pancreatic cancer	1.54e-05	0.000586	CbGpPWpGaD
Clofarabine—Pain—Epirubicin—pancreatic cancer	1.53e-05	0.00027	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—RB1—pancreatic cancer	1.53e-05	0.000583	CbGpPWpGaD
Clofarabine—DCK—Metabolism—CD44—pancreatic cancer	1.53e-05	0.000582	CbGpPWpGaD
Clofarabine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	1.51e-05	0.000266	CcSEcCtD
Clofarabine—Paraesthesia—Doxorubicin—pancreatic cancer	1.49e-05	0.000262	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—CCND1—pancreatic cancer	1.48e-05	0.000566	CbGpPWpGaD
Clofarabine—Dyspnoea—Doxorubicin—pancreatic cancer	1.48e-05	0.000261	CcSEcCtD
Clofarabine—Feeling abnormal—Epirubicin—pancreatic cancer	1.48e-05	0.00026	CcSEcCtD
Clofarabine—Somnolence—Doxorubicin—pancreatic cancer	1.48e-05	0.00026	CcSEcCtD
Clofarabine—RRM2—Metabolism—STK11—pancreatic cancer	1.47e-05	0.000561	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Epirubicin—pancreatic cancer	1.47e-05	0.000258	CcSEcCtD
Clofarabine—DCK—Metabolism—GCG—pancreatic cancer	1.46e-05	0.000558	CbGpPWpGaD
Clofarabine—Decreased appetite—Doxorubicin—pancreatic cancer	1.44e-05	0.000254	CcSEcCtD
Clofarabine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	1.43e-05	0.000252	CcSEcCtD
Clofarabine—Fatigue—Doxorubicin—pancreatic cancer	1.43e-05	0.000252	CcSEcCtD
Clofarabine—Pain—Doxorubicin—pancreatic cancer	1.42e-05	0.00025	CcSEcCtD
Clofarabine—Body temperature increased—Epirubicin—pancreatic cancer	1.42e-05	0.00025	CcSEcCtD
Clofarabine—Abdominal pain—Epirubicin—pancreatic cancer	1.42e-05	0.00025	CcSEcCtD
Clofarabine—ABCG2—Metabolism—PRSS1—pancreatic cancer	1.38e-05	0.000527	CbGpPWpGaD
Clofarabine—DCK—Metabolism—STK11—pancreatic cancer	1.38e-05	0.000524	CbGpPWpGaD
Clofarabine—Feeling abnormal—Doxorubicin—pancreatic cancer	1.37e-05	0.000241	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—RB1—pancreatic cancer	1.37e-05	0.000521	CbGpPWpGaD
Clofarabine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	1.36e-05	0.000239	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	1.34e-05	0.000512	CbGpPWpGaD
Clofarabine—RRM2—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.33e-05	0.000507	CbGpPWpGaD
Clofarabine—Hypersensitivity—Epirubicin—pancreatic cancer	1.32e-05	0.000233	CcSEcCtD
Clofarabine—Abdominal pain—Doxorubicin—pancreatic cancer	1.31e-05	0.000231	CcSEcCtD
Clofarabine—Body temperature increased—Doxorubicin—pancreatic cancer	1.31e-05	0.000231	CcSEcCtD
Clofarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.3e-05	0.000497	CbGpPWpGaD
Clofarabine—Asthenia—Epirubicin—pancreatic cancer	1.29e-05	0.000227	CcSEcCtD
Clofarabine—Pruritus—Epirubicin—pancreatic cancer	1.27e-05	0.000223	CcSEcCtD
Clofarabine—RRM2—Metabolism—TYMS—pancreatic cancer	1.27e-05	0.000483	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—APOE—pancreatic cancer	1.25e-05	0.000477	CbGpPWpGaD
Clofarabine—Diarrhoea—Epirubicin—pancreatic cancer	1.23e-05	0.000216	CcSEcCtD
Clofarabine—Hypersensitivity—Doxorubicin—pancreatic cancer	1.22e-05	0.000215	CcSEcCtD
Clofarabine—POLA1—Cell Cycle—CDKN2A—pancreatic cancer	1.2e-05	0.000458	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—ARG2—pancreatic cancer	1.2e-05	0.000457	CbGpPWpGaD
Clofarabine—Asthenia—Doxorubicin—pancreatic cancer	1.19e-05	0.00021	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—MYC—pancreatic cancer	1.19e-05	0.000454	CbGpPWpGaD
Clofarabine—Dizziness—Epirubicin—pancreatic cancer	1.19e-05	0.000209	CcSEcCtD
Clofarabine—DCK—Metabolism—TYMS—pancreatic cancer	1.18e-05	0.000451	CbGpPWpGaD
Clofarabine—Pruritus—Doxorubicin—pancreatic cancer	1.17e-05	0.000207	CcSEcCtD
Clofarabine—Vomiting—Epirubicin—pancreatic cancer	1.14e-05	0.000201	CcSEcCtD
Clofarabine—Diarrhoea—Doxorubicin—pancreatic cancer	1.14e-05	0.0002	CcSEcCtD
Clofarabine—POLA1—Cell Cycle, Mitotic—CCND1—pancreatic cancer	1.14e-05	0.000433	CbGpPWpGaD
Clofarabine—Rash—Epirubicin—pancreatic cancer	1.13e-05	0.000199	CcSEcCtD
Clofarabine—Dermatitis—Epirubicin—pancreatic cancer	1.13e-05	0.000199	CcSEcCtD
Clofarabine—RRM1—Metabolism—PIK3CG—pancreatic cancer	1.13e-05	0.00043	CbGpPWpGaD
Clofarabine—Headache—Epirubicin—pancreatic cancer	1.12e-05	0.000198	CcSEcCtD
Clofarabine—Dizziness—Doxorubicin—pancreatic cancer	1.1e-05	0.000193	CcSEcCtD
Clofarabine—RRM1—Metabolism—PPARG—pancreatic cancer	1.09e-05	0.000415	CbGpPWpGaD
Clofarabine—Nausea—Epirubicin—pancreatic cancer	1.07e-05	0.000188	CcSEcCtD
Clofarabine—Vomiting—Doxorubicin—pancreatic cancer	1.06e-05	0.000186	CcSEcCtD
Clofarabine—ABCG2—Metabolism—TYMP—pancreatic cancer	1.05e-05	0.000399	CbGpPWpGaD
Clofarabine—Rash—Doxorubicin—pancreatic cancer	1.05e-05	0.000184	CcSEcCtD
Clofarabine—Dermatitis—Doxorubicin—pancreatic cancer	1.05e-05	0.000184	CcSEcCtD
Clofarabine—Headache—Doxorubicin—pancreatic cancer	1.04e-05	0.000183	CcSEcCtD
Clofarabine—RRM2—Metabolism—APOE—pancreatic cancer	1.03e-05	0.000393	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—CCND1—pancreatic cancer	1.01e-05	0.000387	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CD—pancreatic cancer	9.92e-06	0.000378	CbGpPWpGaD
Clofarabine—Nausea—Doxorubicin—pancreatic cancer	9.86e-06	0.000174	CcSEcCtD
Clofarabine—RRM2—Cell Cycle—TP53—pancreatic cancer	9.78e-06	0.000373	CbGpPWpGaD
Clofarabine—DCK—Metabolism—APOE—pancreatic cancer	9.62e-06	0.000367	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CG—pancreatic cancer	9.29e-06	0.000354	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle, Mitotic—MYC—pancreatic cancer	9.11e-06	0.000347	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PPARG—pancreatic cancer	8.97e-06	0.000342	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CG—pancreatic cancer	8.68e-06	0.000331	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CB—pancreatic cancer	8.65e-06	0.00033	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTGS2—pancreatic cancer	8.57e-06	0.000327	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GLP1R—pancreatic cancer	8.45e-06	0.000322	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PPARG—pancreatic cancer	8.38e-06	0.00032	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—DPYD—pancreatic cancer	8.31e-06	0.000317	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CD—pancreatic cancer	8.17e-06	0.000311	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—MYC—pancreatic cancer	8.14e-06	0.00031	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—SLC2A2—pancreatic cancer	7.89e-06	0.000301	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CD—pancreatic cancer	7.63e-06	0.000291	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PTEN—pancreatic cancer	7.47e-06	0.000285	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CB—pancreatic cancer	7.12e-06	0.000271	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTGS2—pancreatic cancer	7.06e-06	0.000269	CbGpPWpGaD
Clofarabine—POLA1—Cell Cycle—TP53—pancreatic cancer	6.69e-06	0.000255	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CB—pancreatic cancer	6.65e-06	0.000254	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTGS2—pancreatic cancer	6.59e-06	0.000251	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PTEN—pancreatic cancer	6.15e-06	0.000235	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—CD44—pancreatic cancer	6.11e-06	0.000233	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—GCG—pancreatic cancer	5.85e-06	0.000223	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PTEN—pancreatic cancer	5.75e-06	0.000219	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—STK11—pancreatic cancer	5.5e-06	0.00021	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—PIK3CA—pancreatic cancer	5.27e-06	0.000201	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—TYMS—pancreatic cancer	4.74e-06	0.000181	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—PIK3CA—pancreatic cancer	4.34e-06	0.000165	CbGpPWpGaD
Clofarabine—RRM1—Metabolism—AKT1—pancreatic cancer	4.31e-06	0.000164	CbGpPWpGaD
Clofarabine—DCK—Metabolism—PIK3CA—pancreatic cancer	4.06e-06	0.000155	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—APOE—pancreatic cancer	3.85e-06	0.000147	CbGpPWpGaD
Clofarabine—RRM2—Metabolism—AKT1—pancreatic cancer	3.55e-06	0.000135	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CG—pancreatic cancer	3.48e-06	0.000132	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PPARG—pancreatic cancer	3.35e-06	0.000128	CbGpPWpGaD
Clofarabine—DCK—Metabolism—AKT1—pancreatic cancer	3.31e-06	0.000126	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CD—pancreatic cancer	3.06e-06	0.000116	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CB—pancreatic cancer	2.66e-06	0.000102	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTGS2—pancreatic cancer	2.64e-06	0.000101	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PTEN—pancreatic cancer	2.3e-06	8.77e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—PIK3CA—pancreatic cancer	1.62e-06	6.19e-05	CbGpPWpGaD
Clofarabine—ABCG2—Metabolism—AKT1—pancreatic cancer	1.33e-06	5.06e-05	CbGpPWpGaD
